The session arrives on the heels of several significant corporate developments for the Calgary-based cannabis enterprise. Recent activity includes the release of second-quarter fiscal 2026 financial results, the pending acquisition of Northern Helm, and the securing of a C$40 million senior credit facility from BMO. Grover also addressed the company's international expansion, specifically the scaling of its medical cannabis operations in Germany through a majority stake in Remexian Pharma GmbH.
High Tide continues to emphasize its retail-forward model, anchored by its Canna Cabana subsidiary, which currently stands as the world's second-largest cannabis retail brand. With 228 domestic locations and an established presence in the German market, the company maintains a 12% share of the Canadian retail landscape. The Reddit event reflects a long-standing management policy of maintaining unfiltered communication channels with the investors who have supported the company's growth trajectory since its inception.
Comments (0)
No comments yet. Be the first!